跳至主要内容
临床试验/NCT00874952
NCT00874952已完成不适用

Regional Observation of the Metabolic Syndrome

AstraZeneca1 个研究点 分布在 1 个国家目标入组 1,600 人开始时间: 2009年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
1,600
试验地点
1
主要终点
Prevalence of metabolic syndrome in primary care population

研究概览

简要总结

The aim of the study, is to assess the prevalence of metabolic syndrome in Italy on a regional basis, defined according to National Cholesterol Education Program/Adult Treatment Panel III (NCEP/ATPIII) guidelines criteria.

研究设计

研究类型
Observational
观察模型
Ecologic Or Community
时间视角
Cross Sectional

入排标准

年龄范围
40 Years 至 74 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed informed consent
  • Laboratory analysis (lipidic profile and glycemia) performed in the last year

排除标准

  • Subjects with serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's successful participation in the study
  • Pregnancy or breast feeding
  • Patients enrolled in clinical studies which the aim is to evaluate the efficacy and/or tolerability of anti-hypertensive and/or lipid lowering drugs

结局指标

主要结局

Prevalence of metabolic syndrome in primary care population

时间窗: At visit

Concomitant presence of other cardiovascular (CV) risk factors.

时间窗: At visit

次要结局

未报告次要终点

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验